News - Oncology, Celldex Therapeutics


Popular Filters

Bristol-Myers and Celldex to evaluate nivolumab and varlilumab combo


US drug major Bristol-Myers Squibb and biotech firm Celldex Therapeutics have entered into a clinical…

BiotechnologyBristol-Myers SquibbCelldex TherapeuticsnivolumabOncologyResearchvarlilumab

Rindopepimut likely to be Rxed by 36% of surveyed US oncologists for GMB patients


US oncologists surveyed by advisory firm Decision Resources indicate that they would prescribe the emerging…

BiotechnologyCelldex TherapeuticsMarkets & MarketingNorth AmericaOncologyPharmaceuticalrindopepimut

Back to top